T2DM patients with poor glycemic control (>53 mmol/mol) had higher ALT, B%, and HOMA-IR but significantly lower adiponectin levels (7.4 versus 8.6 μg/mL) compared to subjects with good control (<53 mmol/mol). The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.